This contract opportunity is for the supply of parenteral medicines, divided into eight categories based on active ingredients, for a planned procurement period of 36 months. The medicines include paracetamol, hydrocortisone, octreotide, magnesium sulfate 10%, dexmedetomidine, creatine phosphate, ro
Tender closed on 8 Aug 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES INC has awarded 8 contracts to 8 suppliers.
+2 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract opportunity involves the procurement of a specialized medical device known as a transcatheter system with a self-expanding aortic valve. This device is intended for specific clinical indications and will be used by the Department of Interventional Cardiology. The procurement period is
This contract opportunity involves the procurement of parenteral medicines categorized into eight parts based on their active ingredients. The planned procurement period is 36 months and includes the following medicines: paracetamol, hydrocortisone, octreotide, magnesium sulfate 10%, dexmedetomidine
This contract involves the supply of medical, technical, and special gases, including the rental of storage tanks and related services, for a duration of 36 months. A detailed description of the contract's subject is included in the competition documents, section B.2.
This contract involves the procurement of specialized medical materials known as Short-Term Intracardiac Catheter Mechanical Heart Support. These devices are intended for use in the Operating Rooms of the Cardiac Surgery Department, the Interventional Cardiology Department, and the Cardiac Surgery a
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
NHS Supply Chain is procuring external defibrillation equipment, consumables, and support services with phased availability beginning August 2027.
PFRU-2 seeks a supplier for medical rehabilitation equipment with proposals due November 4, 2026.
MMUH Ireland seeks an outsourced dermatology services provider to handle increased patient demand and support departmental capacity.
